IRadimed Corporation
IRMD
$96.90
$0.640.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.43% | 12.91% | 11.73% | 11.04% | 11.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.43% | 12.91% | 11.73% | 11.04% | 11.71% |
| Cost of Revenue | 15.38% | 13.22% | 12.93% | 9.39% | 9.66% |
| Gross Profit | 14.15% | 12.82% | 11.38% | 11.54% | 12.34% |
| SG&A Expenses | 11.50% | 12.07% | 12.76% | 15.53% | 15.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.46% | 11.36% | 12.04% | 11.93% | 12.63% |
| Operating Income | 19.04% | 16.55% | 11.05% | 9.01% | 9.63% |
| Income Before Tax | 16.83% | 13.98% | 10.30% | 10.36% | 11.67% |
| Income Tax Expenses | 16.66% | 14.92% | 8.45% | 10.26% | 10.90% |
| Earnings from Continuing Operations | 16.88% | 13.73% | 10.80% | 10.39% | 11.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.88% | 13.73% | 10.80% | 10.39% | 11.87% |
| EBIT | 19.04% | 16.55% | 11.05% | 9.01% | 9.63% |
| EBITDA | 19.88% | 16.62% | 10.52% | 8.57% | 9.53% |
| EPS Basic | 16.40% | 13.25% | 10.27% | 9.84% | 11.28% |
| Normalized Basic EPS | 15.51% | 13.46% | 9.74% | 9.77% | 11.03% |
| EPS Diluted | 16.64% | 13.13% | 10.86% | 9.82% | 10.28% |
| Normalized Diluted EPS | 15.31% | 13.26% | 9.68% | 9.83% | 11.16% |
| Average Basic Shares Outstanding | 0.41% | 0.43% | 0.46% | 0.50% | 0.53% |
| Average Diluted Shares Outstanding | 0.59% | 0.60% | 0.52% | 0.44% | 0.42% |
| Dividend Per Share | 51.06% | 51.11% | 120.00% | 326.67% | 213.33% |
| Payout Ratio | -0.06% | -0.37% | -0.26% | -0.11% | -0.08% |